Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $33.28 in the prior trading day, Omnicell, Inc (NASDAQ: OMCL) closed at $32.59, down -2.07%. In other words, the price has decreased by -$2.07 from its previous closing price. On the day, 0.56 million shares were traded. OMCL stock price reached its highest trading level at $33.45 during the session, while it also had its lowest trading level at $32.505.
Ratios:
Our goal is to gain a better understanding of OMCL by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.01. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.40. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.16.
On October 31, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $44 to $57. Barclays Upgraded its Underweight to Equal Weight on August 02, 2024, whereas the target price for the stock was revised from $26 to $39.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 14 ’25 when LIPPS RANDALL A bought 10,561 shares for $33.13 per share. The transaction valued at 349,874 led to the insider holds 333,610 shares of the business.
PARRISH MARK W sold 12,000 shares of OMCL for $567,638 on Dec 10 ’24. The Director now owns 58,427 shares after completing the transaction at $47.30 per share. On Dec 10 ’24, another insider, PARRISH MARK W, who serves as the Director of the company, bought 12,000 shares for $46.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OMCL now has a Market Capitalization of 1496998784 and an Enterprise Value of 1482403200. As of this moment, Omnicell,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 66.07, and their Forward P/E ratio for the next fiscal year is 19.24. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 11.69. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.30 while its Price-to-Book (P/B) ratio in mrq is 1.20. Its current Enterprise Value per Revenue stands at 1.29 whereas that against EBITDA is 20.012.
Stock Price History:
The Beta on a monthly basis for OMCL is 0.83, which has changed by -0.25931817 over the last 52 weeks, in comparison to a change of 0.16844666 over the same period for the S&P500. Over the past 52 weeks, OMCL has reached a high of $55.74, while it has fallen to a 52-week low of $22.66. The 50-Day Moving Average of the stock is 8.47%, while the 200-Day Moving Average is calculated to be -8.61%.
Shares Statistics:
The stock has traded on average 530.52K shares per day over the past 3-months and 554790 shares per day over the last 10 days, according to various share statistics. A total of 46.42M shares are outstanding, with a floating share count of 44.40M. Insiders hold about 3.31% of the company’s shares, while institutions hold 104.38% stake in the company. Shares short for OMCL as of 1755216000 were 2039046 with a Short Ratio of 3.84, compared to 1752537600 on 1907176. Therefore, it implies a Short% of Shares Outstanding of 2039046 and a Short% of Float of 6.419999999999999.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 8.0 analysts currently analyzing and rating the stock of Omnicell, Inc (OMCL).The consensus estimate for the next quarter is $0.48, with high estimates of $0.54 and low estimates of $0.43.
Analysts are recommending an EPS of between $1.66 and $1.47 for the fiscal current year, implying an average EPS of $1.55. EPS for the following year is $1.69, with 8.0 analysts recommending between $1.84 and $1.3.
Revenue Estimates
8 analysts predict $295.59M in revenue for the current quarter. It ranges from a high estimate of $298.12M to a low estimate of $294.06M. As of the current estimate, Omnicell, Inc’s year-ago sales were $282.42MFor the next quarter, 8 analysts are estimating revenue of $295.32M. There is a high estimate of $302.42M for the next quarter, whereas the lowest estimate is $283.7M.
A total of 8 analysts have provided revenue estimates for OMCL’s current fiscal year. The highest revenue estimate was $1.16B, while the lowest revenue estimate was $1.14B, resulting in an average revenue estimate of $1.15B. In the same quarter a year ago, actual revenue was $1.11BBased on 8 analysts’ estimates, the company’s revenue will be $1.19B in the next fiscal year. The high estimate is $1.22B and the low estimate is $1.16B.
